We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$296B
AUM Growth
+$22.5B
Cap. Flow
+$7.07B
Cap. Flow %
2.39%
Top 10 Hldgs %
14.04%
Holding
10,482
New
945
Increased
3,995
Reduced
3,455
Closed
1,657

Sector Composition

Rank Sector Weight
1 Technology 13.25%
2 Financials 6.72%
3 Healthcare 6.58%
4 Consumer Discretionary 5.35%
5 Industrials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCWO icon
6126
374Water
SCWO
$37.6M
$86.6K ﹤0.01%
3,622
+3,474
+2,347% +$111K
DVOL icon
6127
First Trust Dorsey Wright Momentum & Low Volatility ETF
DVOL
$73.7M
$86.5K ﹤0.01%
3,275
+2,267
+225% +$58.3K
TMFG icon
6128
Motley Fool Global Opportunities ETF
TMFG
$361M
$86.4K ﹤0.01%
3,234
+1,472
+84% +$37.9K
ESCA icon
6129
Escalade
ESCA
$311M
$86.4K ﹤0.01%
6,470
+5,859
+959% +$79.7K
ABCL icon
6130
AbCellera Biologics
ABCL
$2.12B
$86.3K ﹤0.01%
13,366
-53,532
-80% -$365K
LCTX icon
6131
Lineage Cell Therapeutics
LCTX
$274M
$86.1K ﹤0.01%
61,037
+57,784
+1,776% +$79.9K
FRLN
6132
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$86K ﹤0.01%
33,333
EZPW icon
6133
Ezcorp Inc
EZPW
$1.71B
$85.8K ﹤0.01%
10,238
-11,318
-53% -$98.1K
FCTR icon
6134
First Trust Lunt US Factor Rotation ETF
FCTR
$55.7M
$85.7K ﹤0.01%
3,263
+749
+30% +$19.3K
SCMB icon
6135
Schwab Municipal Bond ETF
SCMB
$3.94B
$85.6K ﹤0.01%
3,304
+2,914
+747% +$75.6K
BKKT icon
6136
Bakkt Inc
BKKT
$337M
$85.4K ﹤0.01%
2,779
+271
+11% +$9.49K
SMLR
6137
DELISTED
Semler Scientific
SMLR
$85.4K ﹤0.01%
3,256
+2,955
+982% +$77.9K
CTXR icon
6138
Citius Pharmaceuticals
CTXR
$18.7M
$85.4K ﹤0.01%
2,845
+2,830
+18,867% +$93.2K
MYFW icon
6139
First Western Financial
MYFW
$306M
$85.3K ﹤0.01%
4,584
+2,053
+81% +$36K
MGF
6140
Aberdeen Government Markets Income Fund
MGF
$92.2M
$85.2K ﹤0.01%
26,542
+1,962
+8% +$6.43K
FTRI icon
6141
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$131M
$84.9K ﹤0.01%
6,756
-1,878
-22% -$24K
CHGX
6142
DELISTED
AXS Change Finance ESG ETF
CHGX
$84.6K ﹤0.01%
2,707
+2,153
+389% +$63.3K
CSML
6143
DELISTED
IndexIQ ETF Trust IQ U.S. Small Cap ETF
CSML
$84.6K ﹤0.01%
2,609
+1,192
+84% +$37.3K
OMGA
6144
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$84.2K ﹤0.01%
15,040
+10,986
+271% +$85.9K
UTEN icon
6145
US Treasury 10 Year Note ETF
UTEN
$288M
$84.2K ﹤0.01%
1,849
+800
+76% +$37.1K
RCKY icon
6146
Rocky Brands
RCKY
$369M
$84.1K ﹤0.01%
4,006
-252
-6% -$5.54K
WKHS icon
6147
Workhorse Group
WKHS
$36.3M
$84K ﹤0.01%
32
+19
+146% +$54.8K
STRS icon
6148
Stratus Properties
STRS
$154M
$83.8K ﹤0.01%
3,194
+1,363
+74% +$30.9K
FCEF icon
6149
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.2M
$83.7K ﹤0.01%
4,329
LONA
6150
LeonaBio Inc
LONA
$72.1M
$83.5K ﹤0.01%
2,830
+481
+20% +$13.7K

Similar funds

UBS Group's Q2 2023 Portfolio in Review

As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
  • UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
  • UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
  • UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
  • UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
  • UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
  • UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.